VanEck Vectors製藥ETF PPH 深 滬
已收盤 08-01 16:00:00 美东时间
84.52
+1.590
+1.92%
華盛通- 最 高84.70
- 今 開83.57
- 成交量 65.62万股
- 最 低 83.38
- 昨 收 82.93
- 總市值 5.40亿
- 52周最高 97.5586
- 市盈率 靜 --
- 換手率 10.27%
- 52周最低 77.0631
- 委 比 -1.60%
- 總股本 638.81万
- 歷史最高 97.5586
- 量 比 1.07
- 振 幅 1.59%
- 歷史最低 32.0136
- 每 手 1
- 風險率 3.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sanofi's Q2 Earnings Fall Short On Expectations Despite 21% Jump In Dupixent Sales
Sanofi Q2 sales rose 10.1% at constant currency, led by Dupixent and ALTUVIIIO. EPS missed estimates; 2025 sales guidance was revised upward.
07-31 22:10
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing
ProPhase Labs, Inc. has closed a $3 million private placement financing with senior secured convertible notes and warrants to support working capital, debt repayment, and crypto strategies. The notes, with a 20% original issue discount, are not convertible for the first four months. Proceeds will also aid in pursuing liquidity events like collecting Covid accounts receivable and selling Nebula Genomics. The company aims to explore a reverse merge...
07-23 12:00
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative
The Board of Directors of ProPhase Labs, Inc. authorized the exploration of a potential reverse merger with a digital asset-focused company to enhance shareholder value and diversify its treasury strategy by acquiring and holding selected digital assets, including Bitcoin. This initiative reflects the company's interest in leveraging opportunities at the intersection of life sciences and financial innovation. ProPhase Labs aims to create scalable...
07-21 12:00
Top rated and bottom rated stocks according to 3 key drivers of performance – UBS
UBS analysts listed top and bottom-ranked stocks based on a key set of drivers for equities, they named REVS. UBS’s REVS framework consists of elements that are key drivers for equity performance, inc...
07-11 23:33
SA Quant's top healthcare picks amid Q2 earnings season
The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV), which tracks the health care sector, and holds a weightage of 12.12% in the S&P 500 index, fell 0.91% so far this year, compared to 6.78% r...
07-11 21:35
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.
07-11 19:57
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
06-20 17:59
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.
05-19 15:50
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
Pharma ETFs closely watched as Trump's drug policies stir market volatility. Funds offer sector exposure but differ in risk levels and growth potential.
05-09 00:08
Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage
Novo Nordisk's Wegovy receives FDA approval for expanded use, targeting a significant reduction in cardiovascular events and weight management.
2024-03-09 03:36
公司簡介
公司名稱
|
VanEck Vectors制药ETF
|
行業分類
|
--
|
業務描述
|
Exists as exchange Traded Fund
|
Sanofi's Q2 Earnings Fall Short On Expectations Despite 21% Jump In Dupixent Sales
Sanofi Q2 sales rose 10.1% at constant currency, led by Dupixent and ALTUVIIIO. EPS missed estimates; 2025 sales guidance was revised upward.
07-31 22:10
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing
ProPhase Labs, Inc. has closed a $3 million private placement financing with senior secured convertible notes and warrants to support working capital, debt repayment, and crypto strategies. The notes, with a 20% original issue discount, are not convertible for the first four months. Proceeds will also aid in pursuing liquidity events like collecting Covid accounts receivable and selling Nebula Genomics. The company aims to explore a reverse merge...
07-23 12:00
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative
The Board of Directors of ProPhase Labs, Inc. authorized the exploration of a potential reverse merger with a digital asset-focused company to enhance shareholder value and diversify its treasury strategy by acquiring and holding selected digital assets, including Bitcoin. This initiative reflects the company's interest in leveraging opportunities at the intersection of life sciences and financial innovation. ProPhase Labs aims to create scalable...
07-21 12:00
Top rated and bottom rated stocks according to 3 key drivers of performance – UBS
UBS analysts listed top and bottom-ranked stocks based on a key set of drivers for equities, they named REVS. UBS’s REVS framework consists of elements that are key drivers for equity performance, inc...
07-11 23:33
SA Quant's top healthcare picks amid Q2 earnings season
The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV), which tracks the health care sector, and holds a weightage of 12.12% in the S&P 500 index, fell 0.91% so far this year, compared to 6.78% r...
07-11 21:35
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.
07-11 19:57
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
06-20 17:59
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.
05-19 15:50
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
Pharma ETFs closely watched as Trump's drug policies stir market volatility. Funds offer sector exposure but differ in risk levels and growth potential.
05-09 00:08
Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage
Novo Nordisk's Wegovy receives FDA approval for expanded use, targeting a significant reduction in cardiovascular events and weight management.
2024-03-09 03:36
年度
|
派息內容
| 派息日期 |
0.61
|
2025-07-07
| |
0.52
|
2025-04-04
| |
0.41
|
2024-12-30
| |
0.41
|
2024-10-04
| |
0.36
|
2024-07-05
| |
0.53
|
2024-04-05
| |
0.31
|
2023-12-29
| |
0.34
|
2023-10-06
| |
0.39
|
2023-07-07
| |
0.66
|
2023-04-10
| |
0.24
|
2022-12-30
| |
0.27
|
2022-10-07
| |
0.25
|
2022-07-08
| |
0.44
|
2022-04-07
| |
0.27
|
2021-12-31
| |
0.35
|
2021-10-07
| |
0.29
|
2021-07-08
| |
0.35
|
2021-04-08
| |
0.27
|
2021-01-05
| |
0.25
|
2020-10-07
| |
0.25
|
2020-07-07
| |
0.34
|
2020-04-07
| |
0.17
|
2020-01-06
| |
0.29
|
2019-10-07
| |
0.28
|
2019-07-08
| |
0.39
|
2019-04-05
| |
0.20
|
2019-01-03
| |
0.23
|
2018-10-05
| |
0.25
|
2018-07-09
| |
0.39
|
2018-04-06
| |
0.15
|
2018-01-03
| |
0.22
|
2017-10-06
| |
0.30
|
2017-07-10
| |
0.47
|
2017-04-07
| |
0.14
|
2017-01-04
| |
0.21
|
2016-10-07
| |
0.29
|
2016-07-08
| |
0.63
|
2016-04-07
| |
0.20
|
2016-01-05
| |
0.28
|
2015-10-07
| |
0.28
|
2015-07-08
| |
0.50
|
2015-04-08
| |
0.24
|
2015-01-05
| |
0.20
|
2014-10-07
| |
0.25
|
2014-07-08
| |
0.40
|
2014-04-07
| |
0.17
|
2014-01-03
| |
0.21
|
2013-10-07
| |
0.27
|
2013-07-08
| |
0.39
|
2013-04-05
| |
1.35
|
2012-12-31
| |
0.04
|
2012-02-03
| |
0.13
|
2012-01-11
| |
0.15
|
2011-12-15
| |
0.05
|
2011-12-13
| |
0.14
|
2011-12-08
| |
0.07
|
2011-11-17
| |
0.06
|
2011-11-03
| |
0.11
|
2011-10-12
| |
0.15
|
2011-09-15
| |
0.001
|
2011-09-12
| |
0.05
|
2011-09-13
| |
0.14
|
2011-09-08
| |
0.07
|
2011-08-17
| |
0.05
|
2011-08-03
| |
0.11
|
2011-07-12
| |
0.15
|
2011-06-16
| |
0.001
|
2011-06-14
| |
0.19
|
2011-06-09
| |
0.07
|
2011-05-18
| |
0.05
|
2011-05-04
| |
0.11
|
2011-04-11
| |
0.61
|
2011-03-10
| |
0.14
|
2011-03-17
| |
0.001
|
2011-03-15
| |
0.05
|
2011-03-14
| |
0.14
|
2011-03-03
| |
0.06
|
2011-02-17
| |
0.06
|
2011-02-03
| |
0.11
|
2011-01-11
| |
0.14
|
2010-12-16
| |
0.04
|
2010-12-24
| |
0.001
|
2010-12-03
| |
0.12
|
2010-12-03
| |
0.06
|
2010-11-17
| |
0.06
|
2010-11-03
| |
0.11
|
2010-10-12
| |
0.004
|
2010-10-06
| |
0.14
|
2010-09-16
| |
0.001
|
2010-09-09
| |
0.05
|
2010-09-14
| |
0.13
|
2010-09-03
| |
0.06
|
2010-08-18
| |
0.06
|
2010-08-04
| |
0.11
|
2010-07-12
| |
0.003
|
2010-07-07
| |
0.14
|
2010-06-17
| |
0.001
|
2010-06-10
| |
0.04
|
2010-06-14
| |
0.13
|
2010-06-03
| |
0.06
|
2010-05-19
| |
0.06
|
2010-05-05
| |
0.11
|
2010-04-09
| |
0.003
|
2010-04-07
| |
0.13
|
2010-03-11
| |
0.001
|
2010-03-16
| |
0.05
|
2010-03-12
| |
0.13
|
2010-03-04
| |
0.06
|
2010-02-18
| |
0.06
|
2010-02-03
| |
0.11
|
2010-01-12
| |
0.004
|
2010-01-06
| |
0.13
|
2009-12-10
| |
0.05
|
2009-12-14
| |
1.47
|
2009-11-16
| |
0.001
|
2009-12-02
| |
0.11
|
2009-12-03
| |
0.009
|
2009-12-02
| |
3.96
|
2009-10-27
| |
0.06
|
2009-11-04
| |
0.08
|
2009-10-05
| |
0.003
|
2009-10-07
| |
0.13
|
2009-09-10
| |
0.001
|
2009-09-10
| |
0.05
|
2009-09-14
| |
0.04
|
2009-09-03
| |
0.10
|
2009-09-04
| |
0.06
|
2009-08-19
| |
0.06
|
2009-08-05
| |
0.17
|
2009-07-03
| |
0.13
|
2009-06-11
| |
0.001
|
2009-06-10
| |
0.05
|
2009-07-08
| |
0.04
|
2009-06-03
| |
0.09
|
2009-06-04
| |
0.009
|
2009-05-28
| |
0.06
|
2009-05-19
| |
0.05
|
2009-05-05
| |
0.01
|
2009-04-08
| |
0.13
|
2009-04-03
| |
0.12
|
2009-03-12
| |
0.001
|
2009-03-17
| |
0.09
|
2009-03-04
| |
0.19
|
2009-03-05
| |
0.05
|
2009-02-19
| |
0.06
|
2009-02-04
| |
0.01
|
2009-01-07
| |
0.08
|
2009-01-06
| |
0.12
|
2008-12-11
| |
0.05
|
2008-12-12
| |
0.04
|
2008-12-03
| |
0.001
|
2008-12-03
| |
0.19
|
2008-12-04
| |
0.05
|
2008-11-19
| |
0.06
|
2008-10-05
| |
0.08
|
2008-10-03
| |
0.12
|
2008-09-11
| |
0.01
|
2008-09-05
| |
0.05
|
2008-09-09
| |
0.03
|
2008-09-04
| |
0.19
|
2008-09-05
| |
0.009
|
2008-08-28
| |
0.05
|
2008-08-19
| |
0.06
|
2008-08-05
| |
0.08
|
2008-07-03
| |
0.12
|
2008-06-12
| |
0.001
|
2008-06-17
| |
0.01
|
2008-06-03
| |
0.05
|
2008-06-12
| |
0.03
|
2008-06-04
| |
0.19
|
2008-06-05
| |
0.009
|
2008-05-29
| |
0.05
|
2008-05-19
| |
0.06
|
2008-05-05
| |
0.01
|
2008-04-07
| |
0.08
|
2008-04-03
| |
0.11
|
2008-03-13
| |
0.05
|
2008-03-12
| |
0.03
|
2008-03-05
| |
0.19
|
2008-03-06
| |
0.009
|
2008-02-28
| |
0.05
|
2008-02-20
| |
0.05
|
2008-02-05
| |
0.08
|
2008-01-04
| |
0.11
|
2007-12-13
| |
0.01
|
2007-12-04
| |
0.04
|
2007-12-12
| |
0.010
|
2007-12-04
| |
0.03
|
2007-12-05
| |
0.17
|
2007-12-06
| |
0.009
|
2007-11-29
| |
0.05
|
2007-11-19
| |
0.05
|
2007-11-05
| |
0.08
|
2007-10-03
| |
0.11
|
2007-09-13
| |
0.01
|
2007-09-05
| |
0.001
|
2007-09-11
| |
0.04
|
2007-09-12
| |
0.03
|
2007-09-06
| |
0.17
|
2007-09-07
| |
0.009
|
2007-08-30
| |
0.05
|
2007-08-17
| |
0.05
|
2007-08-03
| |
0.001
|
2007-07-18
| |
0.01
|
2007-09-05
| |
0.08
|
2007-07-05
| |
0.11
|
2007-06-14
| |
0.01
|
2007-05-31
| |
0.001
|
2007-06-12
| |
0.08
|
2007-06-12
| |
0.20
|
2007-06-05
| |
0.009
|
2007-05-31
| |
0.05
|
2007-05-17
| |
0.05
|
2007-05-03
| |
0.001
|
2007-04-18
| |
0.01
|
2007-04-05
| |
0.08
|
2007-04-04
| |
0.10
|
2007-03-15
| |
0.001
|
2007-03-13
| |
0.04
|
2007-03-13
| |
0.03
|
2007-03-05
| |
0.17
|
2007-03-08
| |
0.008
|
2007-03-01
| |
0.04
|
2007-02-20
| |
0.02
|
2007-01-24
| |
0.001
|
2007-01-08
| |
0.08
|
2007-01-04
| |
0.005
|
2006-12-04
| |
0.04
|
2006-12-12
| |
0.03
|
2006-12-05
| |
0.64
|
2006-12-07
| |
0.008
|
2006-11-30
| |
0.04
|
2006-11-17
| |
0.05
|
2006-11-03
| |
0.001
|
2006-10-18
| |
0.08
|
2006-10-04
| |
0.10
|
2006-09-14
| |
0.006
|
2006-09-14
| |
0.0008
|
2006-09-05
| |
0.04
|
2006-09-12
| |
0.16
|
2006-09-07
| |
0.008
|
2006-08-31
| |
0.04
|
2006-08-17
| |
0.05
|
2006-08-03
| |
0.001
|
2006-07-18
| |
0.08
|
2006-07-06
| |
0.10
|
2006-06-15
| |
0.004
|
2006-06-02
| |
0.001
|
2006-06-15
| |
0.0008
|
2006-06-05
| |
0.04
|
2006-06-13
| |
0.16
|
2006-06-08
| |
0.008
|
2006-06-01
| |
0.04
|
2006-05-17
| |
0.06
|
2006-05-02
| |
0.003
|
2006-04-19
| |
0.0008
|
2006-04-03
| |
0.08
|
2006-04-05
| |
0.09
|
2006-03-16
| |
0.001
|
2006-03-16
| |
0.04
|
2006-03-14
| |
0.03
|
2006-03-03
| |
0.13
|
2006-03-09
| |
0.62
|
2006-03-02
| |
0.04
|
2006-02-17
| |
0.05
|
2006-02-03
| |
0.001
|
2006-01-18
| |
0.08
|
2006-01-06
| |
0.02
|
2005-12-16
| |
0.09
|
2005-12-15
| |
0.0008
|
2005-12-05
| |
0.001
|
2005-12-14
| |
0.03
|
2005-12-13
| |
0.14
|
2005-12-05
| |
0.008
|
2005-12-01
| |
0.04
|
2005-11-17
| |
0.05
|
2005-11-03
| |
0.001
|
2005-10-19
| |
0.08
|
2005-10-05
| |
0.09
|
2005-09-15
| |
0.0008
|
2005-09-06
| |
0.05
|
2005-08-03
| |
0.001
|
2005-07-19
| |
0.08
|
2005-06-07
| |
0.18
|
2005-06-10
| |
0.008
|
2005-06-02
| |
0.05
|
2005-05-04
| |
0.0007
|
2005-04-19
| |
0.08
|
2005-04-05
| |
0.11
|
2005-03-14
| |
0.001
|
2005-03-14
| |
0.11
|
2005-03-03
| |
0.008
|
2005-03-02
| |
0.04
|
2005-02-17
| |
0.0008
|
2005-01-28
| |
0.05
|
2005-02-03
| |
0.0007
|
2005-01-19
| |
0.08
|
2005-01-05
| |
0.07
|
2004-12-09
| |
0.03
|
2004-12-14
| |
0.09
|
2004-12-07
| |
0.0009
|
2004-12-13
| |
0.008
|
2004-12-02
| |
0.04
|
2004-11-17
| |
0.0008
|
2004-10-29
| |
0.05
|
2004-11-04
| |
0.0007
|
2004-10-19
| |
0.08
|
2004-10-05
| |
0.0009
|
2004-09-20
| |
0.07
|
2004-09-09
| |
0.12
|
2004-09-08
| |
0.008
|
2004-09-02
| |
0.04
|
2004-08-18
| |
0.0008
|
2004-07-30
| |
0.05
|
2004-08-04
| |
0.0007
|
2004-07-19
| |
0.08
|
2004-07-06
| |
0.07
|
2004-06-10
| |
0.12
|
2004-06-14
| |
0.03
|
2004-06-03
| |
0.0009
|
2004-06-14
| |
0.008
|
2004-06-02
| |
0.04
|
2004-05-19
| |
0.0008
|
2004-04-30
| |
0.05
|
2004-05-05
| |
0.0007
|
2004-04-19
| |
0.08
|
2004-04-05
| |
0.06
|
2001-09-10
| |
0.02
|
2001-09-12
| |
0.03
|
2001-09-04
| |
0.02
|
2001-08-30
| |
0.03
|
2001-08-17
| |
0.0008
|
2001-07-27
| |
0.04
|
2001-08-03
| |
0.0004
|
2001-07-18
| |
0.07
|
2001-07-03
| |
0.05
|
2001-06-13
| |
0.06
|
2001-06-18
| |
0.02
|
2001-06-12
| |
0.03
|
2001-06-04
| |
0.02
|
2001-05-30
| |
0.03
|
2001-05-16
| |
0.0008
|
2001-04-26
| |
0.04
|
2001-05-02
| |
0.0004
|
2001-04-17
| |
0.07
|
2001-04-03
| |
0.04
|
2001-03-14
| |
0.0009
|
2001-03-19
| |
0.02
|
2001-03-12
| |
0.03
|
2001-03-02
| |
0.02
|
2001-02-28
| |
0.04
|
2001-02-02
| |
0.0004
|
2001-01-16
| |
0.07
|
2001-01-03
| |
0.04
|
2000-12-13
| |
0.0008
|
2000-12-11
| |
0.03
|
2000-12-04
| |
0.02
|
2000-11-29
| |
0.0007
|
2000-10-31
| |
0.03
|
2000-11-16
| |
0.04
|
2000-11-02
| |
0.0004
|
2000-10-16
| |
0.07
|
2000-10-03
| |
0.0008
|
2000-09-18
| |
0.04
|
2000-09-13
| |
0.05
|
2000-09-08
| |
0.03
|
2000-09-12
| |
0.03
|
2000-09-05
| |
0.02
|
2000-08-30
| |
0.0007
|
2000-08-04
| |
0.03
|
2000-08-16
| |
0.04
|
2000-08-02
| |
0.0004
|
2000-07-17
| |
0.0003
|
2000-07-05
| |
0.06
|
2000-07-05
| |
0.0008
|
2000-06-19
| |
0.04
|
2000-06-14
| |
0.03
|
2000-06-12
| |
0.03
|
2000-06-02
| |
0.03
|
2000-06-09
| |
0.02
|
2000-05-31
| |
0.02
|
2000-05-15
| |
0.03
|
2000-05-16
| |
0.010
|
2000-05-02
| |
0.04
|
2000-05-02
| |
0.0002
|
2000-04-04
| |
0.06
|
2000-04-04
| |
0.03
|
2000-03-13
| |
0.05
|
2000-03-13
|
